460
Views
85
CrossRef citations to date
0
Altmetric
Methodology

Confounding in observational studies based on large health care databases: problems and potential solutions – a primer for the clinician

, &
Pages 185-193 | Published online: 28 Mar 2017

References

  • RothmanKJModern Epidemiology1st edBoston, MALittle, Brown and Company1986
  • SennSSeven myths of randomisation in clinical trialsStat Med20133291439145023255195
  • BrittonAMcKeeMBlackNMcPhersonKSandersonCBainCThreats to applicability of randomised trials: exclusions and selective participationJ Health Serv Res Policy19994211212110387403
  • BoothCMTannockIFRandomised controlled trials and population-based observational research: partners in the evolution of medical evidenceBr J Cancer2014110355155524495873
  • ReyesCPottegardASchwarzPReal-life and RCT participants: alendronate users versus FITs’ trial eligibility criterionCalcif Tissue Int201699324324927099132
  • FrankLEpidemiology. When an entire country is a cohortScience200028754622398239910766613
  • HulleySBCummingsSRBrownerWSGradyDHearstNNewmanTBDesigning Clinical Research2nd edPhiladelphiaLippincott Williams & Wilkins2001
  • VanderWeeleTJHernanMARobinsJMCausal directed acyclic graphs and the direction of unmeasured confounding biasEpidemiology200819572072818633331
  • FleischerNLDiez RouxAVUsing directed acyclic graphs to guide analyses of neighbourhood health effects: an introductionJ Epidemiol Community Health200862984284618701738
  • SchmidtMJacobsenJBLashTLBotkerHESorensenHT25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort studyBMJ2012344e35622279115
  • GaistDAndersenLHallasJSorensenHTSchroderHDFriisSUse of statins and risk of glioma: a nationwide case-control study in DenmarkBr J Cancer2013108371572023322196
  • SchmidtMSchmidtSASandegaardJLEhrensteinVPedersenLSorensenHTThe Danish National Patient Registry: a review of content, data quality, and research potentialClin Epidemiol2015744949026604824
  • SogaardMHeide-JorgensenUNorgaardMJohnsenSPThomsenRWEvidence for the low recording of weight status and lifestyle risk factors in the Danish National Registry of Patients, 1999-2012BMC Public Health201515132026715157
  • TottenborgSSThomsenRWNielsenHJohnsenSPFrausingHELangePImproving quality of care among COPD outpatients in Denmark 2008-2011Clin Respir J20137431932723163961
  • SturmerTGlynnRJRothmanKJAvornJSchneeweissSAdjustments for unmeasured confounders in pharmacoepidemiologic database studies using external informationMed Care20074510 Supl 2S158S16517909375
  • SvenssonEHorvath-PuhoEThomsenRWVagotomy and subsequent risk of Parkinson’s diseaseAnn Neurol201578452252926031848
  • BrennerHRothenbacherDBodeGAdlerGRelation of smoking and alcohol and coffee consumption to active Helicobacter pylori infection: cross sectional studyBMJ19973157121148914929420488
  • HernanMATakkoucheBCaamano-IsornaFGestal-OteroJJA meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson’s diseaseAnn Neurol200252327628412205639
  • LashTLFoxMPFinkAKSensitivity Analysis for Unmeasured Confounding Applying Quantitative Bias Analysis to Epidemiological DataOxford, UKSpringer Verlag2009
  • PowersKMKayDMFactorSACombined effects of smoking, coffee, and NSAIDs on Parkinson’s disease riskMov Disord2008231889517987647
  • KjøllerMJKKamper-JørgensenFThe Public Health Report, Denmark 2007Copenhagen2007 Available from: http://www.si-folkesundhed.dk/Udgivelser/B%C3%B8ger%20og%20rapporter/2008/2897%20Folke-sundhedsrapporten%202007.aspx?lang=enAccessed February 15, 2017
  • YoshidaKSolomonDHKimSCActive-comparator design and new-user design in observational studiesNat Rev Rheumatol201511743744125800216
  • SchneeweissSRassenJAGlynnRJAvornJMogunHBrookhartMAHigh-dimensional propensity score adjustment in studies of treatment effects using health care claims dataEpidemiology200920451252219487948
  • BoscoJLSillimanRAThwinSSA most stubborn bias: no adjustment method fully resolves confounding by indication in observational studiesJ Clin Epidemiol2010631647419457638
  • FreemantleNMarstonLWaltersKWoodJReynoldsMRPetersenIMaking inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational researchBMJ2013347f640924217206
  • TohSGarcia RodriguezLAHernanMAConfounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical recordsPharmacoepidemiol Drug Saf201120884985721717528
  • HallasJPottegardAPerformance of the high-dimensional propensity score in a Nordic healthcare modelBasic Clin Pharmacol Toxicol2017120331231727889951
  • GarbeEKlossSSulingMPigeotISchneeweissSHigh-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complicationsEur J Clin Pharmacol201369354955722763756
  • WilliamsonEMorleyRLucasACarpenterJPropensity scores: from naive enthusiasm to intuitive understandingStat Methods Med Res201221327329321262780
  • PatornoEGlynnRJHernandez-DiazSLiuJSchneeweissSStudies with many covariates and few outcomes: selecting covariates and implementing propensity-score-based confounding adjustmentsEpidemiology201425226827824487209
  • MaclureMThe case-crossover design: a method for studying transient effects on the risk of acute eventsAm J Epidemiol199113321441531985444
  • FarringtonCPRelative incidence estimation from case series for vaccine safety evaluationBiometrics19955112282357766778
  • PetersenIDouglasIWhitakerHSelf controlled case series methods: an alternative to standard epidemiological study designsBMJ2016354i451527618829
  • WhitakerHJFarringtonCPSpiessensBMusondaPTutorial in biostatistics: the self-controlled case series methodStat Med200625101768179716220518
  • SuissaSThe case-time-control designEpidemiology1995632482537619931
  • LundJLOstgardLSPrandoniPSorensenHTde NullyBPIncidence, determinants and the transient impact of cancer treatments on venous thromboembolism risk among lymphoma patients in DenmarkThromb Res2015136591792326371409
  • SchneeweissSPatrickARSturmerTIncreasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial resultsMed Care20074510 Supl 2S131S14217909372
  • ThomsenRWPedersenLMollerNKahlertJBeck-NielsenHSorensenHTIncretin-based therapy and risk of acute pancreatitis: a nationwide population-based case-control studyDiabetes Care20153861089109825633664
  • GreenlandSAn introduction to instrumental variables for epidemiologistsInt J Epidemiol200029472272910922351
  • BrookhartMARassenJASchneeweissSInstrumental variable methods in comparative safety and effectiveness researchPharmacoepidemiol Drug Saf201019653755420354968
  • BoefAGle CessieSDekkersOMPhysician’s prescribing preference as an instrumental variable: exploring assumptions using survey dataEpidemiology201627227628326605813
  • BoefAGvanPJArbousMSPhysician’s preference-based instrumental variable analysis: is it valid and useful in a moderate-sized study?Epidemiology201425692392725051311
  • SmithGDEbrahimSMendelian randomization: prospects, potentials, and limitationsInt J Epidemiol2004331304215075143
  • BuckleyDIFuRFreemanMRogersKHelfandMC-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task ForceAnn Intern Med2009151748349519805771
  • ZachoJTybjaerg-HansenAJensenJSGrandePSillesenHNordestgaardBGGenetically elevated C-reactive protein and ischemic vascular diseaseN Engl J Med2008359181897190818971492
  • BorJMoscoeEMutevedziPNewellMLBarnighausenTRegression discontinuity designs in epidemiology: causal inference without randomized trialsEpidemiology201425572973725061922
  • O’KeeffeAGGenelettiSBaioGSharplesLDNazarethIPetersenIRegression discontinuity designs: an approach to the evaluation of treatment efficacy in primary care using observational dataBMJ2014349g529325199521
  • VandenbrouckeJPle CessieSCommentary: regression discontinuity design: let’s give it a try to evaluate medical and public health interventionsEpidemiology201425573874125076150
  • LipsitchMTchetgenTECohenTNegative controls: a tool for detecting confounding and bias in observational studiesEpidemiology201021338338820335814
  • JacksonLAJacksonMLNelsonJCNeuzilKMWeissNSEvidence of bias in estimates of influenza vaccine effectiveness in seniorsInt J Epidemiol200635233734416368725
  • JohannesdottirSAHorvath-PuhoEDekkersOMUse of gluco-corticoids and risk of venous thromboembolism: a nationwide population-based case-control studyJAMA Intern Med2013173974375223546607
  • LawlorDATillingKDavey SmithGTriangulation in aetiological epidemiologyInt J Epidemiol Epub2017120
  • SlaughterJLReaganPBNewmanTBKlebanoffMAComparative effectiveness of nonsteroidal anti-inflammatory drug treatment vs no treatment for patent ductus arteriosus in preterm infantsJAMA Pediatr Epub201713
  • IsongIARichmondTKawachiIAvendanoMChildcare attendance and obesity riskPediatrics20161385e2016153927940780
  • ValleyTSWalkeyAJLindenauerPKWienerRSCookeCRAssociation between noninvasive ventilation and mortality among older patients with pneumoniaCrit Care Med Epub2016105
  • CarrollRMetcalfeCSteegSPsychosocial assessment of self-harm patients and risk of repeat presentation: an instrumental variable analysis using time of hospital presentationPLoS One2016112e014971326918579
  • BoefAGSouvereinPCVandenbrouckeJPInstrumental variable analysis as a complementary analysis in studies of adverse effects: venous thromboembolism and second-generation versus third-generation oral contraceptivesPharmacoepidemiol Drug Saf201625331732426749045
  • BrookeBSGoodneyPPKraissLWGottliebDJSamoreMHFinlaysonSRReadmission destination and risk of mortality after major surgery: an observational cohort studyLancet2015386999688489526093917